Decreased mean platelet volume predicts poor prognosis in metastatic colorectal cancer patients treated with first-line chemotherapy: results from mCRC biomarker study

Decreased mean platelet volume predicts poor prognosis in metastatic colorectal cancer patients treated with first-line chemotherapy: results from mCRC biomarker study

Abstract Background Metastatic colorectal cancer (mCRC) is a major cause of death of malignant tumor and the valuable prognostic biomarker for chemotherapy is crucial in decreasing mortality. Previous studies have proved the prognostic value of the mean platelet volume (MPV) in survival of primary o...

Full description

Bibliographic Details
Main Authors: Jinjia Chang, Guangyi Lin, Min Ye, Duo Tong, Jing Zhao, Dan Zhu, Qihe Yu, Wen Zhang, Wenhua Li
Format: Article
Language:English
Published: BMC 2019-01-01
Series:BMC Cancer
Subjects:
MPV
Metastatic colorectal cancer
Chemotherapy
Biomarker
Online Access:http://link.springer.com/article/10.1186/s12885-018-5252-2

Similar Items

Similar Items